Russell O. Pieper

8.8k total citations · 1 hit paper
105 papers, 6.7k citations indexed

About

Russell O. Pieper is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Russell O. Pieper has authored 105 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Molecular Biology, 35 papers in Genetics and 23 papers in Cancer Research. Recurrent topics in Russell O. Pieper's work include Glioma Diagnosis and Treatment (34 papers), DNA Repair Mechanisms (19 papers) and Epigenetics and DNA Methylation (16 papers). Russell O. Pieper is often cited by papers focused on Glioma Diagnosis and Treatment (34 papers), DNA Repair Mechanisms (19 papers) and Epigenetics and DNA Methylation (16 papers). Russell O. Pieper collaborates with scholars based in United States, Canada and Japan. Russell O. Pieper's co-authors include Mitchel S. Berger, Yuichi Hirose, Amith Panner, Andrew T. Parsa, Courtney A. Crane, J Costello, Sabrina M. Ronen, Tomohiro Kawaguchi, Bernard W. Futscher and Makoto Katayama and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and Nature Communications.

In The Last Decade

Russell O. Pieper

105 papers receiving 6.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma

2006 1.1k citations Andrew T. Parsa, James S. Waldron et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Russell O. Pieper United States	44	3.9k	2.1k	1.9k	1.7k	1.2k	105	6.7k
Katrin Lamszus Germany	53	3.8k 1.0×	2.2k 1.1×	2.5k 1.3×	2.1k 1.2×	1.0k 0.9×	154	7.8k
Do‐Hyun Nam South Korea	43	3.6k 0.9×	2.4k 1.1×	2.2k 1.1×	2.2k 1.3×	735 0.6×	144	7.1k
Robert Soriano United States	19	2.7k 0.7×	1.5k 0.7×	1.8k 0.9×	1.5k 0.8×	639 0.6×	20	5.1k
Lenny Dang United States	26	5.0k 1.3×	1.5k 0.7×	2.3k 1.2×	3.7k 2.2×	1.1k 0.9×	50	8.3k
Sandra Pastorino United States	32	3.0k 0.8×	1.8k 0.9×	1.7k 0.9×	1.8k 1.1×	718 0.6×	59	6.3k
Shakti Ramkissoon United States	37	2.8k 0.7×	1.6k 0.8×	1.8k 0.9×	1.9k 1.1×	761 0.7×	204	6.9k
Qing Shi China	11	4.1k 1.1×	3.7k 1.8×	2.5k 1.3×	2.6k 1.5×	677 0.6×	19	7.5k
Arnab Chakravarti United States	45	3.2k 0.8×	1.3k 0.6×	1.2k 0.6×	2.1k 1.2×	473 0.4×	173	6.1k
Sith Sathornsumetee United States	32	3.4k 0.9×	2.2k 1.1×	4.1k 2.1×	2.5k 1.5×	495 0.4×	89	7.5k
Weishi Yuan United States	13	2.6k 0.7×	1.3k 0.6×	2.9k 1.5×	2.1k 1.2×	583 0.5×	20	6.3k

Countries citing papers authored by Russell O. Pieper

Since Specialization

Citations

This map shows the geographic impact of Russell O. Pieper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Russell O. Pieper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Russell O. Pieper more than expected).

Fields of papers citing papers by Russell O. Pieper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Russell O. Pieper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Russell O. Pieper. The network helps show where Russell O. Pieper may publish in the future.

Co-authorship network of co-authors of Russell O. Pieper

This figure shows the co-authorship network connecting the top 25 collaborators of Russell O. Pieper. A scholar is included among the top collaborators of Russell O. Pieper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Russell O. Pieper. Russell O. Pieper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schupp, Patrick G., Samuel J. Shelton, Brett Johnson, et al.. (2024). Deconstructing Intratumoral Heterogeneity through Multiomic and Multiscale Analysis of Serial Sections. Cancers. 16(13). 2429–2429. 2 indexed citations

Viswanath, Pavithra, Georgios Batsios, Vinay Ayyappan, et al.. (2021). Metabolic imaging detects elevated glucose flux through the pentose phosphate pathway associated with TERT expression in low-grade gliomas. Neuro-Oncology. 23(9). 1509–1522. 26 indexed citations

Subramani, Elavarasan, Marina Radoul, Chloé Najac, et al.. (2020). Glutamate Is a Noninvasive Metabolic Biomarker of IDH1-Mutant Glioma Response to Temozolomide Treatment. Cancer Research. 80(22). 5098–5108. 22 indexed citations

Mukherjee, Joydeep, Tor‐Christian Johannessen, Shigeo Ohba, et al.. (2018). Mutant IDH1 Cooperates with ATRX Loss to Drive the Alternative Lengthening of Telomere Phenotype in Glioma. Cancer Research. 78(11). 2966–2977. 65 indexed citations

Viswanath, Pavithra, Marina Radoul, José Luis Izquierdo-García, et al.. (2018). 2-Hydroxyglutarate-Mediated Autophagy of the Endoplasmic Reticulum Leads to an Unusual Downregulation of Phospholipid Biosynthesis in Mutant IDH1 Gliomas. Cancer Research. 78(9). 2290–2304. 40 indexed citations

Viswanath, Pavithra, Marina Radoul, José Luis Izquierdo-García, et al.. (2018). Mutant IDH1 gliomas downregulate phosphocholine and phosphoethanolamine synthesis in a 2-hydroxyglutarate-dependent manner. SHILAP Revista de lepidopterología. 6(1). 3–3. 35 indexed citations

Ohba, Shigeo, Joydeep Mukherjee, Andrew Mancini, et al.. (2016). Mutant IDH1 Expression Drives TERT Promoter Reactivation as Part of the Cellular Transformation Process. Cancer Research. 76(22). 6680–6689. 50 indexed citations

Izquierdo-García, José Luis, Pavithra Viswanath, Pia Eriksson, et al.. (2015). IDH1 Mutation Induces Reprogramming of Pyruvate Metabolism. Cancer Research. 75(15). 2999–3009. 98 indexed citations

Park, Ilwoo, Joydeep Mukherjee, Motokazu Ito, et al.. (2014). Changes in Pyruvate Metabolism Detected by Magnetic Resonance Imaging Are Linked to DNA Damage and Serve as a Sensor of Temozolomide Response in Glioblastoma Cells. Cancer Research. 74(23). 7115–7124. 58 indexed citations

10.

Izquierdo-García, José Luis, Larry Cai, Myriam M. Chaumeil, et al.. (2014). Glioma Cells with the IDH1 Mutation Modulate Metabolic Fractional Flux through Pyruvate Carboxylase. PLoS ONE. 9(9). e108289–e108289. 60 indexed citations

11.

See, Wendy L., I‐Li Tan, Joydeep Mukherjee, Theodore Nicolaides, & Russell O. Pieper. (2012). Sensitivity of Glioblastomas to Clinically Available MEK Inhibitors Is Defined by Neurofibromin 1 Deficiency. Cancer Research. 72(13). 3350–3359. 79 indexed citations

12.

Nakamura, Jean L., Emile Pinarbasi, Scott C. Kogan, et al.. (2011). Dose-Dependent Effects of Focal Fractionated Irradiation on Secondary Malignant Neoplasms in Nf1 Mutant Mice. Cancer Research. 71(1). 106–115. 24 indexed citations

13.

Han, Seunggu J., Brian Ahn, James S. Waldron, et al.. (2009). Gamma interferon-mediated superinduction of B7-H1 in PTEN-deficient glioblastoma: a paradoxical mechanism of immune evasion. Neuroreport. 20(18). 1597–1602. 35 indexed citations

14.

Dinca, Eduard B., Kan Lu, Jann N. Sarkaria, et al.. (2008). p53 Small-Molecule Inhibitor Enhances Temozolomide Cytotoxic Activity against Intracranial Glioblastoma Xenografts. Cancer Research. 68(24). 10034–10039. 42 indexed citations

15.

Panner, Amith, Jean L. Nakamura, Andrew T. Parsa, et al.. (2006). mTOR-Independent Translational Control of the Extrinsic Cell Death Pathway by RalA. Molecular and Cellular Biology. 26(20). 7345–7357. 23 indexed citations

16.

Kawaguchi, Tomohiro, Yoji Yamashita, Masayuki Kanamori, et al.. (2006). The PTEN/Akt Pathway Dictates the Direct αVβ3-Dependent Growth-Inhibitory Action of an Active Fragment of Tumstatin in Glioma Cells In vitro and In vivo. Cancer Research. 66(23). 11331–11340. 40 indexed citations

17.

Sonoda, Yukihiko, Masayuki Kanamori, Dennis F. Deen, et al.. (2003). Overexpression of vascular endothelial growth factor isoforms drives oxygenation and growth but not progression to glioblastoma multiforme in a human model of gliomagenesis.. PubMed. 63(8). 1962–8. 32 indexed citations

18.

Pieper, Russell O.. (1997). Understanding and manipulating O6-methylguanine-DNA methyltransferase expression. Pharmacology & Therapeutics. 74(3). 285–297. 56 indexed citations

19.

Watts, George S., et al.. (1997). Methylation of Discrete Regions of the O ⁶ -Methylguanine DNA Methyltransferase (MGMT) CpG Island Is Associated with Heterochromatinization of the MGMT Transcription Start Site and Silencing of the Gene. Molecular and Cellular Biology. 17(9). 5612–5619. 192 indexed citations

20.

Pieper, Russell O., Susan E. Morgan, & Mark R. Kelley. (1994). The role of two conserved amino acids, glutamine 90 and asparagine 137, in O⁶-methylguanine-DNA methyltransferase stability, activity and substrate specificity. Carcinogenesis. 15(9). 1895–1902. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact